Literature DB >> 86715

Synthetic enkephalin analogue in treatment of schizophrenia.

A Jørgensen, R Fog, B Veilis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86715     DOI: 10.1016/s0140-6736(79)91426-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Effects of D-Met2, Pro5-enkephalinamide on pain tolerance and some cognitive functions in man.

Authors:  J I Székely; K Török; I Karczag; J Tolna; M Till
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats.

Authors:  J J Balsara; N V Nandal; N P Burte; J H Jadhav; A G Chandorkar
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects.

Authors:  R Weizman; A Weizman; S Tyano; G Szekely; B A Weissman; Y Sarne
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 4.  Neuropeptides in dopamine-containing regions of the brain.

Authors:  A Albanese; M C Altavista
Journal:  Ital J Neurol Sci       Date:  1984-12

5.  Enkephalin, morphine, and naloxone in tardive dyskinesia.

Authors:  N Bjørndal; D E Casey; J Gerlach
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 6.  Peptide neuroregulators: the opioid system as a model.

Authors:  J D Barchas; C Evans; G R Elliott; P A Berger
Journal:  Yale J Biol Med       Date:  1985 Nov-Dec

7.  Neuropeptides and monoaminergic neurotransmitters: their relation to pain.

Authors:  W H Sweet
Journal:  J R Soc Med       Date:  1980-07       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.